Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Sees Strong Trading Volume – Still a Buy?

Shares of Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) saw unusually-strong trading volume on Thursday . 175,605 shares were traded during trading, an increase of 33% from the previous session’s volume of 132,286 shares.The stock last traded at $9.51 and had previously closed at $9.14.

Analysts Set New Price Targets

A number of research analysts have issued reports on the stock. Jefferies Financial Group upgraded shares of Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 14th. Zacks Research raised shares of Shionogi & Co., Ltd. Unsponsored ADR from a “strong sell” rating to a “hold” rating in a research note on Monday, May 25th. Finally, The Goldman Sachs Group upgraded shares of Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a research report on Monday, June 15th. Two investment analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy”.

Shionogi & Co., Ltd. Unsponsored ADR Stock Up 1.9%

The firm has a 50-day simple moving average of $8.88 and a 200 day simple moving average of $9.70. The stock has a market capitalization of $16.24 billion, a P/E ratio of 9.54, a P/E/G ratio of 3.38 and a beta of 0.08. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.58 and a quick ratio of 1.46.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last announced its quarterly earnings results on Monday, August 3rd. The company reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.18. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 46.67% and a return on equity of 16.47%. The firm had revenue of $1.04 billion during the quarter, compared to analysts’ expectations of $970.69 million. On average, equities research analysts forecast that Shionogi & Co., Ltd. Unsponsored ADR will post 0.8 EPS for the current year.

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.